Oncotarget, Author at Oncotarget

Oncotarget News

New Ultra-Sensitive DNA Blood Test for Detecting Residual Cancer in B-cell Lymphoma Patients

May 19, 2025

Collectively, the data presented here suggest that the PhasED-Seq-based MRD assay is accurate and reproducible, making it appropriate for use in the clinical setting for individuals with B-cell malignancies."BUFFALO,... read more

Oncotarget

Blood Type A Identified as Potential Breast Cancer Risk Factor

May 14, 2025

This study highlights the potential of blood type A as a risk factor for breast cancer compared to blood type O."BUFFALO, NY - May 14, 2025 – A new review paper... read more

Oncotarget

METTL3 Drives Oral Cancer by Blocking Tumor-Suppressing Gene

May 9, 2025

we report that METTL3, an oncogene regulates the expression of SMAD4, a tumor-suppressor via miR-146a-5p, thus unveiling a novel regulatory axis of METTL3/miR-146a-5p/SMAD4 in OSCC, which can potentially... read more

Oncotarget

Oncotarget Participation at SSP 2025 Annual Meeting

May 5, 2025

Oncotarget will be represented by Impact Journals as an exhibitor at the Society for Scholarly Publishing (SSP) 47th Annual Meeting, taking place from May 28–30, 2025, in Baltimore, Maryland.... read more

Oncotarget

Early Immune Evasion Found in HPV-Related Pre-Cancer Lesions of the Anogenital Region

April 28, 2025

This study demonstrated that the inflammatory response in a subset of anal, penile, and vulvar HSILs was associated with PD-L1 and FOXP3 expression."BUFFALO, NY - April 28, 2025 – A new... read more

Oncotarget

Gene Variant Linked to Benign Prostate Hyperplasia Risk in Lebanese Men

April 15, 2025

Our results indicate a strong association between certain genotypes of the SNP -765 G>C of the PTGS2 gene and BPH."BUFFALO, NY - April 15, 2025 – A new research... read more